160 related articles for article (PubMed ID: 34225753)
1. Effect of first-line biologic initiation on glucocorticoid exposure in children hospitalized with new-onset systemic juvenile idiopathic arthritis: emulation of a pragmatic trial using observational data.
Peterson RG; Xiao R; Katcoff H; Fisher BT; Weiss PF
Pediatr Rheumatol Online J; 2021 Jul; 19(1):109. PubMed ID: 34225753
[TBL] [Abstract][Full Text] [Related]
2. Variation in Treatment of Children Hospitalized With New-Onset Systemic Juvenile Idiopathic Arthritis in the US.
Peterson RG; Xiao R; James KE; Katcoff H; Fisher BT; Weiss PF
Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1714-1721. PubMed ID: 33242366
[TBL] [Abstract][Full Text] [Related]
3. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
Nigrovic PA; Beukelman T; Tomlinson G; Feldman BM; Schanberg LE; Kimura Y;
Clin Trials; 2018 Jun; 15(3):268-277. PubMed ID: 29542334
[TBL] [Abstract][Full Text] [Related]
4. Treatment of systemic JIA: When do we need a biologic? Real world data of a single center.
Adiguzel Dundar H; Acari C; Turkucar S; Unsal E
Mod Rheumatol; 2021 May; 31(3):684-690. PubMed ID: 32343644
[TBL] [Abstract][Full Text] [Related]
5. The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.
Janow G; Schanberg LE; Setoguchi S; Hasselblad V; Mellins ED; Schneider R; Kimura Y;
J Rheumatol; 2016 Sep; 43(9):1755-62. PubMed ID: 27307527
[TBL] [Abstract][Full Text] [Related]
6. Systemic Juvenile Idiopathic Arthritis.
Lee JJY; Schneider R
Pediatr Clin North Am; 2018 Aug; 65(4):691-709. PubMed ID: 30031494
[TBL] [Abstract][Full Text] [Related]
7. Growth Failure in Children with Systemic Juvenile Idiopathic Arthritis and Prolonged Inflammation despite Treatment with Biologicals: Late Normalization of Height by Combined Hormonal Therapies.
de Zegher F; Reynaert N; De Somer L; Wouters C; Roelants M
Horm Res Paediatr; 2018; 90(5):337-343. PubMed ID: 29940586
[TBL] [Abstract][Full Text] [Related]
8. First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
Beukelman T; Tomlinson G; Nigrovic PA; Dennos A; Del Gaizo V; Jelinek M; Riordan ME; Schanberg LE; Mohan S; Pfeifer E; Kimura Y;
Pediatr Rheumatol Online J; 2022 Dec; 20(1):113. PubMed ID: 36482434
[TBL] [Abstract][Full Text] [Related]
9. Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.
Horneff G; Schulz AC; Klotsche J; Hospach A; Minden K; Foeldvari I; Trauzeddel R; Ganser G; Weller-Heinemann F; Haas JP
Arthritis Res Ther; 2017 Nov; 19(1):256. PubMed ID: 29166924
[TBL] [Abstract][Full Text] [Related]
10. Systemic onset juvenile idiopathic arthritis: a single center experience.
Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
[TBL] [Abstract][Full Text] [Related]
11. Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.
Hinze CH; Holzinger D; Lainka E; Haas JP; Speth F; Kallinich T; Rieber N; Hufnagel M; Jansson AF; Hedrich C; Winowski H; Berger T; Foeldvari I; Ganser G; Hospach A; Huppertz HI; Mönkemöller K; Neudorf U; Weißbarth-Riedel E; Wittkowski H; Horneff G; Foell D;
Pediatr Rheumatol Online J; 2018 Jan; 16(1):7. PubMed ID: 29357887
[TBL] [Abstract][Full Text] [Related]
12. The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart review.
Shenoi S; Horneff G; Cidon M; Ramanan AV; Kimura Y; Quartier P; Foeldvari I; Zeft A; Lomax KG; Gregson J; Abma T; Campbell-Hill S; Weiss J; Patel D; Marinsek N; Wulffraat N
Clin Exp Rheumatol; 2018; 36(5):920-928. PubMed ID: 29600940
[TBL] [Abstract][Full Text] [Related]
13. Decreasing trend in the incidence of serious pneumonias in Finnish children with juvenile idiopathic arthritis.
Salonen PH; Salonen JH; Säilä H; Helminen M; Linna M; Kauppi MJ
Clin Rheumatol; 2020 Mar; 39(3):853-860. PubMed ID: 31732822
[TBL] [Abstract][Full Text] [Related]
14. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
Kimura Y; Grevich S; Beukelman T; Morgan E; Nigrovic PA; Mieszkalski K; Graham TB; Ibarra M; Ilowite N; Klein-Gitelman M; Onel K; Prahalad S; Punaro M; Ringold S; Toib D; Van Mater H; Weiss JE; Weiss PF; Schanberg LE;
Pediatr Rheumatol Online J; 2017 Apr; 15(1):23. PubMed ID: 28399931
[TBL] [Abstract][Full Text] [Related]
15. Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives.
Ambler WG; Nanda K; Onel KB; Shenoi S
Ann Med; 2022 Dec; 54(1):1839-1850. PubMed ID: 35786149
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids in the management of systemic juvenile idiopathic arthritis.
Vannucci G; Cantarini L; Giani T; Marrani E; Moretti D; Pagnini I; Simonini G; Cimaz R
Paediatr Drugs; 2013 Oct; 15(5):343-9. PubMed ID: 23813411
[TBL] [Abstract][Full Text] [Related]
17. Effect of biologic treatments on growth in children with juvenile idiopathic arthritis.
Uettwiller F; Perlbarg J; Pinto G; Bader-Meunier B; Mouy R; Compeyrot-Lacassagne S; Melki I; Wouters C; Prieur AM; Landais P; Polak M; Quartier P
J Rheumatol; 2014 Jan; 41(1):128-35. PubMed ID: 24293576
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
Schmeling H; Minden K; Foeldvari I; Ganser G; Hospach T; Horneff G
Arthritis Rheumatol; 2014 Sep; 66(9):2580-9. PubMed ID: 24942886
[TBL] [Abstract][Full Text] [Related]
19. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid treatment in juvenile idiopathic arthritis.
Batu ED
Rheumatol Int; 2019 Jan; 39(1):13-27. PubMed ID: 30276425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
